20-185
Showing 1 - 25 of >10,000
Advanced Breast Cancer Trial in Poland, Turkey (Plasma soluble TNF receptor pulldown, Plasma soluble TNF receptor pulldown +
Recruiting
- Advanced Breast Cancer
- Plasma soluble TNF receptor pulldown
- +2 more
-
Kraków, Małopolskie, Poland
- +4 more
Mar 9, 2022
Pneumococcal Disease Trial (20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine)
Recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- 13-valent pneumococcal conjugate vaccine
-
Budapest, Hungary
- +33 more
Jan 11, 2023
Relapsed/Refractory B Cell Malignancies, Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia
Active, not recruiting
- Relapsed/Refractory B Cell Malignancies
- +3 more
-
Columbus, Ohio
- +17 more
Aug 18, 2022
Hyperemia Eye Trial (Naphazoline / Hypromellose Ophthalmic)
Not yet recruiting
- Hyperemia Eye
- Naphazoline / Hypromellose Ophthalmic
- (no location specified)
Jul 22, 2022
Endometriosis Trial in Worldwide (Relugolix, Estradiol/norethindrone acetate)
Active, not recruiting
- Endometriosis
- Relugolix
- Estradiol/norethindrone acetate
-
Andalusia, Alabama
- +168 more
May 31, 2022
COVID-19, SARS-CoV2 Trial in Miami Beach, Omaha, Sioux Falls (SAB-185, Normal Saline)
Active, not recruiting
- COVID-19
- SARS-CoV2
- SAB-185
- Normal Saline
-
Miami Beach, Florida
- +2 more
Oct 25, 2021
Indolent Non-hodgkin Lymphoma Trial in Worldwide (Duvelisib)
Active, not recruiting
- Indolent Non-hodgkin Lymphoma
-
Washington, District of Columbia
- +39 more
May 17, 2021
Relapsed DLBCL, Refractory DLBCL Trial in Worldwide (Loncastuximab Tesirine, Rituximab, Gemcitabine)
Recruiting
- Relapsed Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- Loncastuximab Tesirine
- +3 more
-
La Jolla, California
- +59 more
Aug 4, 2022
COPD (COPD) Trial in Worldwide (BGF MDI HFO 320/14.4/9.6 µg, BGF MDI HFA 320/14.4/9.6 µg)
Recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- BGF MDI HFO 320/14.4/9.6 μg
- BGF MDI HFA 320/14.4/9.6 μg
-
Phoenix, Arizona
- +96 more
Jan 23, 2023
Vasomotor Symptoms, Menopausal Symptoms Trial in Worldwide (Estetrol oral tablet, Placebo oral tablet, Progesterone oral tablet)
Recruiting
- Vasomotor Symptoms
- Menopausal Symptoms
- Estetrol oral tablet
- +2 more
-
Phoenix, Arizona
- +188 more
May 9, 2022
Colorectal Cancer Metastatic, Myelosuppression-Adult, Chemotherapeutic Toxicity Trial in Worldwide (Trilaciclib, Placebo)
Active, not recruiting
- Colorectal Cancer Metastatic
- +2 more
- Trilaciclib
- Placebo
-
Tucson, Arizona
- +81 more
Jan 3, 2023
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
HER2-positive Breast Cancer Trial in China (TQB2440 injection + Trastuzumab + Docetaxel, Perjeta + Trastuzumab + Docetaxel)
Active, not recruiting
- HER2-positive Breast Cancer
- TQB2440 injection + Trastuzumab + Docetaxel
- Perjeta + Trastuzumab + Docetaxel
-
Chongqing, Chongqing, China
- +5 more
Aug 3, 2023
Heart Failure, Chronic Kidney Disease Trial in Worldwide (AZD9977, Dapagliflozin)
Recruiting
- Heart Failure
- Chronic Kidney Disease
-
Hot Springs National Park, Arkansas
- +279 more
Feb 1, 2023
Blood Pressure Trial in Cloppenburg (Polso™ Watch blood pressure measurement compared to a reference blood pressure measurement)
Recruiting
- Blood Pressure
- Polso™ Watch blood pressure measurement compared to a reference blood pressure measurement
-
Cloppenburg, Low Saxony, GermanyIPPMed - Institute for Pharmacology and Preventive Medicine GmbH
Feb 9, 2023
Advanced NSCLC, Metastatic NSCLC Trial in Worldwide (MRTX849 Monotherapy, MRTX849 in Combination with Pembrolizumab)
Recruiting
- Advanced Non-Small Cell Lung Cancer
- Metastatic Non-Small Cell Lung Cancer
- MRTX849 Monotherapy
- +2 more
-
Prescott Valley, Arizona
- +134 more
Jan 25, 2023
Two Methods for Assessing Knee Joint Position Sense
Not yet recruiting
- Patellofemoral Pain Syndrome
- smart phone application and AutoCAD software
-
Cairo, Egyptfaculty of physical therapy- Cairo university
Oct 19, 2022
COVID-19 Trial in New York (Tocilizumab)
Active, not recruiting
- COVID-19
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022